Cryo Cell International Inc

CCELNYSECIK 862692HealthcareFiscal year ends Nov 30

Share this page

Link

Story card, 1080 × 1920

Reports and events: 256 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

Cryo Cell International Inc, Reports and events
Filed	Form	What it is	Accession number
2018-07-2621:01 ET	DEF 14A	Proxy statementPeriod 2018-08-13	0001193125-18-227909
2018-07-1720:02 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0001193125-18-219667
2018-07-1621:23 ET	10-Q	Quarterly reportPeriod 2018-05-31	0001193125-18-218864
2018-06-1520:01 ET	8-K	1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits	0001193125-18-194459
2018-06-0413:10 ET	8-K	1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits	0001193125-18-182606
2018-05-2420:05 ET	8-K	5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits	0001193125-18-173552
2018-04-1820:04 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0001193125-18-121029
2018-04-1621:22 ET	10-Q	Quarterly reportPeriod 2018-02-28	0001193125-18-118744
2018-03-1316:36 ET	8-K	5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits	0001193125-18-080398
2018-03-0121:32 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0001193125-18-067305
2018-02-2821:58 ET	10-K	Annual reportPeriod 2017-11-30	0001193125-18-064199
2018-02-1522:24 ET	SC 13D/A	Ownership report, active investor, amended	0001193125-18-047423
2017-10-1721:17 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0001193125-17-311911
2017-10-1721:13 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0001193125-17-311905
2017-10-1620:02 ET	10-Q	Quarterly reportPeriod 2017-08-31	0001193125-17-310883
2017-07-1821:19 ET	8-K	5.07 Shareholder vote results	0001193125-17-230411
2017-07-0721:04 ET	10-Q	Quarterly reportPeriod 2017-05-31	0001193125-17-224319
2017-06-2621:01 ET	DEF 14A	Proxy statementPeriod 2017-07-18	0001193125-17-213395
2017-04-1715:19 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0001193125-17-125401
2017-04-1321:19 ET	10-Q	Quarterly reportPeriod 2017-02-28	0001193125-17-123411
2017-03-0622:24 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0001193125-17-071853
2017-02-2822:27 ET	10-K	Annual reportPeriod 2016-11-30	0001193125-17-062739
2016-11-0321:20 ET	8-K	1.02 Termination of a material agreement; 9.01 Financial statements and exhibits	0001193125-16-759073
2016-10-1721:28 ET	10-Q	Quarterly reportPeriod 2016-08-31	0001193125-16-739879
2016-10-1321:00 ET	8-K	8.01 Other events; 9.01 Financial statements and exhibits	0001193125-16-737745
2016-08-3021:00 ET	8-K	8.01 Other events; 9.01 Financial statements and exhibits	0001193125-16-696964
2016-08-0118:12 ET	8-K	8.01 Other events; 9.01 Financial statements and exhibits	0001193125-16-666311
2016-07-1220:37 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0001193125-16-646390
2016-07-1121:29 ET	10-Q	Quarterly reportPeriod 2016-05-31	0001193125-16-645605
2016-07-0720:20 ET	8-K	5.07 Shareholder vote results	0001193125-16-643449
2016-07-0121:24 ET	8-K	8.01 Other events	0001193125-16-640607
2016-06-2421:26 ET	8-K	1.01 Entry into a material agreement; 9.01 Financial statements and exhibits	0001193125-16-631702
2016-06-2121:04 ET	DEF 14A	Proxy statementPeriod 2016-07-06	0001193125-16-627902
2016-05-2621:05 ET	8-K	2.03 New direct financial obligation; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits	0001193125-16-604450
2016-04-2020:50 ET	8-K	5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits	0001193125-16-548359
2016-04-1921:27 ET	8-K	5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits	0001193125-16-546715
2016-04-1421:16 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0001193125-16-541627
2016-04-1420:09 ET	10-Q	Quarterly reportPeriod 2016-02-29	0001193125-16-541409
2016-04-1322:28 ET	SC 13D/A	Ownership report, active investor, amended	0001193125-16-538790
2016-03-1821:28 ET	8-K	4.01 Change of auditor; 9.01 Financial statements and exhibits	0001193125-16-510540
2016-03-1821:19 ET	8-K	5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits	0001193125-16-510527
2016-03-1421:02 ET	8-K	5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits	0001193125-16-503638
2016-03-0222:06 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0001193125-16-490195
2016-02-2922:40 ET	10-K	Annual reportPeriod 2015-11-30	0001193125-16-485790
2015-10-1521:26 ET	10-Q	Quarterly reportPeriod 2015-08-31	0001193125-15-344846
2015-07-1720:01 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0001193125-15-255972
2015-07-1620:15 ET	8-K	1.01 Entry into a material agreement; 9.01 Financial statements and exhibits	0001193125-15-254853
2015-07-1521:28 ET	10-Q	Quarterly reportPeriod 2015-05-31	0001193125-15-253772
2015-07-1317:16 ET	8-K	5.07 Shareholder vote results; 9.01 Financial statements and exhibits	0001193125-15-251009
2015-06-1921:01 ET	8-K	1.01 Entry into a material agreement; 9.01 Financial statements and exhibits	0001193125-15-228991

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 14:58 ET. Listed shows no prices and gives no investment advice.